By L.B. Bohle
To get in touch with L.B. Bohle, simply fill out the form below.
Subscribe to Supplier
L.B. Bohle showing advanced manufacturing solutions to Asia Pharma Bangladesh
Ennigerloh, Germany: – World-respected builder of advanced systems for pharma production, L.B. Bohle, will show its wide range of advanced pharmaceutical manufacturing machinery in early March at the 14th Asia Pharma Expo in the Bangladeshi capital, Dhaka.
The L.B. Bohle stand at Booth C116 at the ICCB exhibition center in Dhaka will present the broad portfolio of its production and process platforms, for oral solid dose and other manufacturing, including advances in Continuous Manufacturing (CM), high containment, and R&D. These include highly advanced machines for wet and dry granulation, milling and sieving, container blending, tablet coating, and product handling, done under high containment where necessary.
Fast growing market
L.B. Bohle solutions are becoming increasingly relevant in Bangladesh, which is fast expanding to become one of the world’s principle pharma manufacturing centers, with market growth of close to 20 per cent per year. The country now has around 350 pharma manufacturing facilities and exports more than 95% of its production to more than countries worldwide.
L.B. Bohle’s presence in Dhaka will be headed by Parag Radia, Director of Sales for L.B. Bohle India, along with Area Sales Manager, Ingo Küsel from Germany.
“We are delighted to be returning to Asia Pharma Expo, as really valuable event that allows us to address this dynamic market by presenting our whole portfolio and meeting so many prospective partners and existing clients,’ commented Mr. Radia.
About L.B. Bohle
Founded in 1981, L.B. Bohle Maschinen und Verfahren GmbH (L.B. Bohle) has established a worldwide reputation as a producer and supplier of advanced systems for pharmaceutical manufacturing, based on a track record of technological innovation and continuous improvement.
Based at Ennigerloh in Northwest Germany, L.B. Bohle operates worldwide, offering advanced solutions for every aspect of oral solid dose (OSD) and nutraceutical tablet production, including weighing & dosing, grinding & sieving, blending, tablet coating, sorting, handling systems, cleaning and containment, process monitoring and continuous manufacturing.
The company’s guiding vision is one of technological innovation in the production of pharmaceutical solids. This supports a core mission to deliver maximum product efficiency increases for its customers, through continuous development and product innovations that not only increase quality and efficiency, but also strengthen competitive edge and sustainability.
To these ends, L.B. Bohle offers both complete production lines and solutions for individual production steps, focusing on rapid development and production of sophisticated, pragmatic, and customized applications.
The company operates development and manufacturing facilities at its home base at Ennigerloh and at Sassenberg, both in North Rhine-Westphalia. Additionally, it has sales and service subsidiaries in the USA (Warminster, PA) in India (Ahmedabad), in Singapore and in Switzerland (Reiden). It is also represented by more than 40 qualified sales partners worldwide, having become a globally recognized brand.
About Asia Pharma Expo 2023
First hosted in 2009, the Asia Pharma Expo Bangladesh is an International Exhibition with its main focus on the exciting and rapidly growing South Asian Pharmaceutical Market.
The 14th Asia Pharma Expo is a three-day event opening March 2, 2023, at the ICCB International Congress Center of Bangladesh in Dhaka, Bangladesh, in parallel with an online exhibition Asia Lab Expo.
The Expo represents the entire pharma market, providing a forum for exhibitors of process machinery, packaging equipment, plant, cleanroom and water treatment engineering, construction, contract manufacturing and supply of ingredient and excipients, to connect with C-level decision makers, regulatory bodies, research and academia.
The events are organised by GPE Expo Pvt Ltd., with further details at: http://asiapharma.org/ape/index.php